Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jing-Ren Tseng

Years Active: 2018-2022
Publications (10 Years): 5

New Taipei City Municipal Tucheng Hospital (Built and Operated by Chang Gung Medical Foundation)

Chang Gung University Department of Medical Imaging and Radiological Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

New Taipei City Municipal Tucheng Hospital (Built and Operated by Chang Gung Medical Foundation) Jul 1o 2020

Taiwan

Director/M.D,Ph.D :: Nuclear Medicine

Education History

Chang Gung University Department of Medical Imaging and Radiological Sciences Sep 1o 2016 - Jun 30o 2020

Taiwan

PHD

Publications

Vuong Thuy Tran, Shu-Ju Tu, Jing-Ren Tseng
68 Ga-PSMA-11 PET/CT Features Extracted from Different Radiomic Zones Predict Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer. Cancers 14 (19) (2022)
Jing-Ren Tseng, Szu-Han Chang, Yao-Yu Wu, Kang-Hsing Fan, Kai-Jie Yu, Lan-Yan Yang, Ing-Tsung Hsiao, Feng-Yuan Liu, See-Tong Pang
Impact of Three-Month Androgen Deprivation Therapy on [68Ga]Ga-PSMA-11 PET/CT Indices in Men with Advanced Prostate Cancer-Results from a Pilot Prospective Study. Cancers 14 (5) (2022)
Hsi-Chen Tsai, Kung-Chu Ho, Shih-Hsin Chen, Jing-Ren Tseng, Lan-Yan Yang, Kun-Ju Lin, Ju-Chin Cheng, Miaw-Jene Liou
Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal. Diagnostics (Basel, Switzerland) 12 (1) (2022)
Jing-Ren Tseng, Yu-Han Chang, Lan-Yan Yang, Chen-Te Wu, Szu-Yuan Chen, Chih-Hsing Wan, Ing-Tsung Hsiao, Tzu-Chen Yen
Potential usefulness of 68Ga-citrate PET/CT in detecting infected lower limb prostheses. EJNMMI research 9 (1) (2019)
Jing-Ren Tseng, Lan-Yan Yang, Yu-Chun Lin, Chung-Yi Liu, See-Tong Pang, Ji-Hong Hong, Tzu-Chen Yen, Li-Jen Wang
Metabolic Volumetric Parameters in 11C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer. Contrast media & molecular imaging 2018 (2018)

Jing-Ren Tseng.css-eqlu8i{font-size:small;padding-left:4px;}